Stryker's Trading Volume Drops 30.6% to $320 Million Ranking 289th in Market Activity

On July 11, 2025, Stryker's trading volume reached $320 million, a 30.6% decrease from the previous day, ranking 289th in the day's stock market activity. Stryker's stock price fell by 1.35%.

Analysts anticipate that Stryker will report earnings per share (EPS) of $13.35 for the full year, marking a 9.5% increase from $12.19 in fiscal 2024. The EPS is projected to rise by 11% year over year to $14.82. For the next earnings release, the company is expected to report earnings of $3.06 per share, reflecting an 8.9% year-over-year increase. Based on 13 analysts' forecasts, the consensus EPS forecast for the quarter is $3.06. Additionally, research analysts expect Stryker to post an EPS of $13.47 for the current year.

Stryker is set to announce its financial results for the second quarter of fiscal year 2025. The company recently received FDA clearance for its Incompass Total Ankle System, a significant development that could impact its future performance. This clearance is expected to enhance Stryker's product offerings and potentially drive growth in the orthopedic market.